Market Research Report
Global Human Vaccines Market 2011-2015
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||245855|
|Published||Content info||42 Pages
This publication has been discontinued on November 12, 2015.
TechNavio's analysts forecast the Global Human Vaccines market to reach US$57.6 billion by 2015. One of the key factors contributing to this market growth is the increase in demand for vaccination against communicable diseases. The Global Human Vaccines market has also been witnessing the increase in awareness programs worldwide. However, emergence of vaccine-resistant viruses could pose a challenge to the growth of this market.
TechNavio's report, the Global Human Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include GlaxoSmithKline plc, Merck and Co. Inc., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report:: ALK Abello A/S, AstraZeneca plc, Bavarian Nordic A/S, Baxter International Inc., CSL Ltd., MedImmune Inc., Novartis AG, Shanta Biotechnics Ltd., Sinovac Biotech Ltd., and Vaxin Inc.
You can request one free hour of analyst time when you purchase this report. Details provided within the report.